1. Home
  2. BNL vs TNGX Comparison

BNL vs TNGX Comparison

Compare BNL & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadstone Net Lease Inc.

BNL

Broadstone Net Lease Inc.

N/A

Current Price

$17.58

Market Cap

3.7B

Sector

Real Estate

ML Signal

N/A

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

N/A

Current Price

$22.03

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BNL
TNGX
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.1B
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
BNL
TNGX
Price
$17.58
$22.03
Analyst Decision
Buy
Strong Buy
Analyst Count
11
13
Target Price
$22.50
★ $47.09
AVG Volume (30 Days)
2.8M
★ 4.5M
Earning Date
10-28-2026
11-13-2026
Dividend Yield
★ 6.90%
N/A
EPS Growth
N/A
★ 26.89
EPS
★ 0.58
N/A
Revenue
★ $454,138,000.00
$62,384,000.00
Revenue This Year
$8.96
N/A
Revenue Next Year
$9.71
N/A
P/E Ratio
$29.48
★ N/A
Revenue Growth
5.17
★ 48.29
52 Week Low
$16.70
$7.37
52 Week High
$23.10
$34.39

Technical Indicators

Market Signals
Indicator
BNL
TNGX
Relative Strength Index (RSI) 42.38 44.87
Support Level N/A $20.46
Resistance Level $19.93 $25.68
Average True Range (ATR) 0.51 1.73
MACD 0.04 -0.17
Stochastic Oscillator 39.35 10.99

Price Performance

Historical Comparison
BNL
TNGX

About BNL Broadstone Net Lease Inc.

Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: